Advertisement

Topics

WIN Consortium to conduct targeted tri-therapy trial for NSCLC

19:00 EDT 9 Aug 2017 | Net Resources International

French non-profit healthcare network WIN Consortium (WIN) is set to conduct a clinical trial (SPRING) of a new three targeted therapies combination as first-line treatment for patients with advanced non-small-cell lung cancer (NSCLC), following appro…

Original Article: WIN Consortium to conduct targeted tri-therapy trial for NSCLC

NEXT ARTICLE

More From BioPortfolio on "WIN Consortium to conduct targeted tri-therapy trial for NSCLC"

Quick Search
Advertisement
 

Relevant Topics

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...